Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.02 USD
Change Today +0.0006 / 3.33%
Volume 715.7K
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

positiveid corp (PSID) Snapshot

Open
$0.02
Previous Close
$0.02
Day High
$0.02
Day Low
$0.02
52 Week High
05/5/14 - $0.09
52 Week Low
04/20/15 - $0.02
Market Cap
4.1M
Average Volume 10 Days
2.6M
EPS TTM
$-0.10
Shares Outstanding
221.4M
EX-Date
08/29/08
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for POSITIVEID CORP (PSID)

Related News

No related news articles were found.

positiveid corp (PSID) Related Businessweek News

View More BusinessWeek News

positiveid corp (PSID) Details

PositiveID Corporation develops molecular diagnostic systems for bio-threat detection and rapid medical testing. The company focuses on microfluidic systems for the automated preparation of and performance of biological assays for the detection of biological threats at high-value locations and analyzes samples in a medical environment. It has a portfolio of intellectual property related to sample preparation and rapid medical testing applications. The company’s M-BAND technology, developed under contract with the U.S. DHS Science & Technology directorate, is a bio-aerosol monitor with integrated systems for sample collection, processing, and detection modules. M-BAND technology analyzes air samples for the detection of pathogenic bacteria, viruses, and toxins for up to 30 days. The company’s Firefly Dx is a handheld, portable system designed to deliver molecular diagnostic results from a sample in less than 30 minutes at the point-of-need. Firefly is being developed for a range of biological detection situations, including radiation-induced cell damage within the human body and strains of influenza, and has demonstrated the ability to detect and identify other common pathogens and diseases, such as E. coli, methicillin-resistant staphylococcus aureus, and human papilloma virus. The company was formerly known as VeriChip Corporation and changed its name to PositiveID Corporation in November 2009. PositiveID Corporation was founded in 2001 and is headquartered in Delray Beach, Florida.

9 Employees
Last Reported Date: 03/30/15
Founded in 2001

positiveid corp (PSID) Top Compensated Officers

Chairman, Chief Executive Officer and Acting ...
Total Annual Compensation: $413.0K
Compensation as of Fiscal Year 2013.

positiveid corp (PSID) Key Developments

PositiveID Corporation Completes Additional Testing of its Phase II Firefly Dx

PositiveID Corporation announced that it has successfully completed additional testing of its phase II Firefly Dx prototype handheld, real-time PCR (polymerase chain reaction) pathogen detection system, and detected multiple organisms with a multiplex assay designed to simultaneously test for up to four pathogens on the Firefly Dx PCR chip. Firefly Dx is designed to provide real-time, accurate diagnostic results in a handheld device, thereby leading to treatment scenarios at the point of need that are not possible with existing systems, which require lab-based equipment and can take hours or even days to provide results. In this stage of multiplex testing, which is one of the intended advantages of Firefly Dx, the Company delivered positive PCR results with consistent and repeated detection of each positive challenge. Firefly's applications include point-of-need, lab-quality, detection of pathogenic organisms; agricultural screening in both domestic sectors and developing countries; and detection of biological agents associated with weapons of mass destruction. The Company intends to continue testing of the phase II prototype, including assays developed by the Company and partners' assays. The Company also intends to continue to decrease the time-to-result on its PCR chip.

PositiveID Corporation Auditor Raises 'Going Concern' Doubt

PositiveID Corporation filed its 10-K on Mar 30, 2015 for the period ending Dec 31, 2014. In this report its auditor, Salberg & Company, P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.

PositiveID Announces First Firefly Dx Testing and Delivery of Positive PCR Results Within 20 Minutes

PositiveID Corporation announced that it has successfully completed its first round of testing of its phase II Firefly Dx prototype handheld real-time PCR (polymerase chain reaction) pathogen detection system, and has delivered positive PCR results within 20 minutes. The company's Firefly Dx testing was performed at standard laboratory volumes and achieved equivalent results to laboratory-based PCR instruments, which can take hours to perform the same PCR process. The company previously announced it completed its Firefly Dx PCR design, and it has now completed successful testing on its Phase II breadboard Firefly Dx system, with consistent and repeated detection of each positive challenge. With the completion of the PCR chip design with confirmatory results, the Company is now in the next phase of testing to encompass optimization and a broader spectrum of tests. Firefly Dx is designed to provide real-time, accurate diagnostic results in a handheld device, thereby leading to treatment scenarios at the point of need that are not possible with existing systems, which require lab-based equipment and can take hours or even days to provide results. Firefly Dx is targeting the global PCR market, which is projected to reach approximately $27.4 billion this year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PSID:US $0.02 USD +0.0006

PSID Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ALR Technologies Inc $0.01 USD 0.00
Medtronic PLC $75.60 USD +1.15
Microsoft Corp $48.66 USD +0.015
View Industry Companies
 

Industry Analysis

PSID

Industry Average

Valuation PSID Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact POSITIVEID CORP, please visit www.psidcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.